https://www.selleckchem.com/products/kpt-330.html
Even treated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) continues to pose a significant burden in patients' everyday functioning and may continuously affect their quality of life (QoL). The aims of our prospective study were to analyze health-related QoL in CIDP patients during a 1-year follow-up period in real-life settings and to compare QoL changes with changes in disability and with patient impression of change. The study comprised 59 patients diagnosed with CIDP. SF-36 questionnaire was applied in order to eva
Like
Comment
Share
